Bonum Therapeutics, Inc.
3 private offerings reported to the SEC on Form D since 2016, $73.1M sold in all. Biotech, WA.
- Form D offerings: 3
- Reported sold: $73.1M
- Newest: Apr 17, 2026
Every Form D Offering
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.| Apr 17, 2026 | $26.9M | $32.3M | Bonum Therapeutics, Inc.Biotech · WA | Not amended | 0001898714-26-000001 |
| Nov 29, 2022 | $45.0M | $93.0M | Bonum Therapeutics, Inc.Biotech · WA | Not amended | 0001898714-22-000001 |
| Dec 22, 2021 | $1.2M | $3.6M | Bonum Therapeutics, Inc.Biotech · WA | Not amended | 0001898714-21-000001 |
SEC Profile
From the company's EDGAR record- Business address
- Seattle, Wa
- Incorporated in
- DE
- All SEC filings
- CIK 1898714 on EDGAR
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR